Assessing inequities in buprenorphine treatment across the care cascade
- 28 February 2025
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 270, 112636
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (K08DA058052)
- National Institutes of Health
- National Center for Advancing Translational Sciences
- Boston University (1UL1TR001430)
This publication has 40 references indexed in Scilit:
- Major Gaps in the Cascade of Care for Opioid Use DisorderJAMA, 2024
- Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment AccessJAMA Network Open, 2023
- Trends in Buprenorphine Initiation and Retention in the United States, 2016-2022JAMA, 2023
- Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug UseJAMA Network Open, 2022
- Disparities by Sex and Race and Ethnicity in Death Rates Due to Opioid Overdose Among Adults 55 Years or Older, 1999 to 2019JAMA Network Open, 2022
- Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patientsDrug and Alcohol Dependence, 2018
- Linking patients with buprenorphine treatment in primary care: Predictors of engagementDrug and Alcohol Dependence, 2017
- Probability and predictors of treatment-seeking for substance use disorders in the U.SDrug and Alcohol Dependence, 2015
- Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adultsDrug and Alcohol Dependence, 2014
- Longitudinal predictors of addictions treatment utilization in treatment-naïve adults with alcohol use disordersDrug and Alcohol Dependence, 2011